A5092614860- Eating Disorders and Behaviors
- Obsessive-Compulsive Spectrum Disorders
- Impact of Technology on Adolescents
- Child Nutrition and Feeding Issues
- Autism Spectrum Disorder Research
- Obesity, Physical Activity, Diet
- Occupational Health and Performance
- Sexuality, Behavior, and Technology
- Body Image and Dysmorphia Studies
- Psychosomatic Disorders and Their Treatments
- Health and Lifestyle Studies
- Pharmacology and Obesity Treatment
- Adipose Tissue and Metabolism
King's College London
2023-2024
Abstract Introduction Antipsychotics are routinely prescribed off‐label for anorexia nervosa (AN) despite limited evidence. This article presents a protocol of study aiming to assess the feasibility future definitive trial on olanzapine in young people with AN. Methods and analysis In an open‐label, one‐armed study, 55 patients AN or atypical AN, aged 12–24, receiving outpatient, inpatient day‐care treatment who considered will be recruited from NHS sites based England. Assessments conducted...
Despite the availability of evidence-based treatments for anorexia nervosa (AN), remission rates are moderate, and mortality is high. Olanzapine used as adjunct therapy AN in case insufficient response to first-line treatments, even though evidence limited. Its effect on eating disorder (ED) psychopathology, its efficacy tolerability, acceptability adherence rate unclear.
<title>Abstract</title> <bold>Background</bold> Despite the availability of evidence-based treatments for anorexia nervosa (AN), remission rates are moderate, and mortality is high. Olanzapine used treatment-resistant AN even though evidence limited. Its effect on eating disorder (ED) psychopathology, its efficacy tolerability, acceptability adherence rate unclear.<bold>Methods</bold> We assessed feasibility a future definitive trial olanzapine in young people with an open-label, one-armed...
Download This Paper Open PDF in Browser Add to My Library Share: Permalink Using these links will ensure access this page indefinitely Copy URL DOI